Sirona Biochem Corp (SBM) — Cash Flow-to-Debt Ratio
Sirona Biochem Corp (SBM) has a Cash Flow-to-Debt Ratio of -0.13x as of July 2024, meaning its operating cash flow of CA$-552.59K could theoretically repay 0% of its total liabilities (CA$4.27 Million) in one year. See Sirona Biochem Corp free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Sirona Biochem Corp Cash Flow-to-Debt Ratio (2011–2023)
Historical debt coverage capacity for Sirona Biochem Corp across 13 annual periods. Also explore Sirona Biochem Corp annual equity growth to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Sirona Biochem Corp (2011–2023)
Year-by-year debt coverage analysis for Sirona Biochem Corp. For market capitalisation and broader financial context, see SBM market cap.
| Year | CF-to-Debt Ratio | Operating CF (CAD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2023 | -0.50x | CA$-1.76 Million | CA$3.54 Million | ▲ +75.5% |
| 2022 | -2.02x | CA$-2.18 Million | CA$1.08 Million | ▼ -29.8% |
| 2021 | -1.56x | CA$-2.16 Million | CA$1.38 Million | ▼ -54.2% |
| 2020 | -1.01x | CA$-2.11 Million | CA$2.09 Million | ▲ +41.3% |
| 2019 | -1.72x | CA$-3.56 Million | CA$2.07 Million | ▼ -779.7% |
| 2018 | -0.20x | CA$-593.35K | CA$3.03 Million | ▲ +74.2% |
| 2017 | -0.76x | CA$-2.50 Million | CA$3.29 Million | ▲ +43.6% |
| 2016 | -1.35x | CA$-2.10 Million | CA$1.56 Million | ▲ +12.0% |
| 2015 | -1.53x | CA$-3.06 Million | CA$2.00 Million | ▼ -34.8% |
| 2014 | -1.14x | CA$-1.86 Million | CA$1.64 Million | ▲ +45.6% |
| 2013 | -2.09x | CA$-2.50 Million | CA$1.20 Million | ▲ +4.9% |
| 2012 | -2.20x | CA$-2.15 Million | CA$976.91K | ▲ +36.7% |
| 2011 | -3.47x | CA$-2.54 Million | CA$732.20K | — |